A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?
The House Financial Services Committee says American consumers are helped by a strong dollar, which lowers the price of imports to the tune of up to $45 billion per year in savings. In a $23 trillion economy, is an overvalued dollar really worth it?
China as a source for American imports is on the wane thanks to tariffs, other business risks. But strong dollar keeps imports booming.
House Homeland Committee leadership say DoJ, FBI, and Homeland have all failed in stopping China espionage, IP theft.
At a recent House Ways & Means subcommittee hearing on trade, CEO Michael Stumo talks de minimis, and the inescapable realities of China’s forced labor.
Dan Kildee’s full floor speech in support of over-riding the President’s veto on House and Senate vote to end the White House solar emergency declaration started last June.
Solar imports are booming thanks in large part to White House’s two year ban on tariffs against China companies in SE Asia.
In latest House Select Committee on China hearing, more tariffs, more Wall Street bans, and more tech restrictions are warranted.
A House Foreign Affairs Subcommittee hears from witnesses about how to curtail exports of critical technologies to China. Some say there are too many lists.
The U.S. is increasingly reliant on imported drugs from uninspected labs. It’s not safe. What can be done about it?